Key reporting guidelines, shaded green, are displayed first. Show the most recently added records first.

1
• CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement
  
2
• Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI) : an extension of the STROBE statement for neonatal infection research
  
3
• STROBE-AMS : recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship
  
4
• Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID) : an extension of the STROBE statement
  
5
• Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug-resistant Organism and Healthcare -Associated Infections Agent-based Modeling Methods
  
6
• Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
  
7
• Reporting guidelines for allergy and immunology survey research
  
8
• STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
  
9
• Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
  
10
• Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
  
11
• Evaluation of post-introduction COVID- 19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
  
12
• Reporting gaps in immunization costing studies: Recommendations for improving the practice
  
13
• Benefit -Risk Assessment of Vaccines. Part II : Proposal Towards Consolidated Standards of Reporting Quantitative Benefit -Risk Models Applied to Vaccines (BRIVAC)
  
14
• Microbiology Investigation Criteria for Reporting Objectively (MICRO) : a framework for the reporting and interpretation of clinical microbiology data
  
15
• Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review
  
16
• Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
  
17
• A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?
  
18
• Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
19
• Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
20
• Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
21
• Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study
  
22
• Minimum data elements for research reports on CFS
  
23
• American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
  
24
• Quality of study methods in individual- and group-level HIV intervention research: critical reporting elements
  
25
• The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection